Selection and characterization of cyclic peptides that bind to a monoclonal antibody against meningococcal L3,7,9 lipopolysaccharides.

@article{Lauvrak2004SelectionAC,
  title={Selection and characterization of cyclic peptides that bind to a monoclonal antibody against meningococcal L3,7,9 lipopolysaccharides.},
  author={Vigdis Lauvrak and G\oril Berntzen and Ulla Heggelund and Tove Karin Herstad and Randi H Sandin and R Dalseg and Einar Rosenqvist and Inger Sandlie and T E Michaelsen},
  journal={Scandinavian journal of immunology},
  year={2004},
  volume={59 4},
  pages={373-84}
}
There is still no general vaccine for prevention of disease caused by group-B meningococcal strains. Meningococcal lipopolysaccharides (LPSs) have received attention as potential vaccine candidates, but concerns regarding their safety have been raised. Peptide mimics of LPS epitopes may represent safe alternatives to immunization with LPS. The monoclonal… CONTINUE READING